Medtronic (NYSE:MDT) PT Raised to $92.00

Medtronic (NYSE:MDT – Get Free Report) had its target price increased by investment analysts at Oppenheimer from $89.00 to $92.00 in a research note issued on Wednesday, Benzinga reports. The firm presently has a “market perform” rating on the medical technology company’s stock. Oppenheimer’s target price indicates a potential upside of 8.16% from the stock’s […]

Leave a Reply

Your email address will not be published.

Previous post Royal Bank of Canada Cuts Axsome Therapeutics (NASDAQ:AXSM) Price Target to $123.00
Next post D.B. Root & Company LLC Sells 31 Shares of Microsoft Co. (NASDAQ:MSFT)